The US IPO market has logged 205 offerings through July 23, 2026 — 6.22% ahead of the 193 recorded at the same point in 2025, according to Stock Analysis, which compiles its figures manually from SEC filings and other official sources. For microcap watchers, the headline number looks encouraging. The fine print is worth reading.
The compositional story is where the 2026 market diverges from a straightforward risk-appetite narrative. SPACs accounted for 69% of US IPO deal volume in the first quarter of 2026, up from 58% in Q4 2025, per FTI Consulting's Q1 2026 IPO & SPAC Market Update. Q1 alone saw 62 SPAC IPOs raise over $11.8 billion — a near fourfold increase in proceeds compared to prior quarters and the highest SPAC issuance level since 2021. That SPAC surge is the primary driver of the count gap between Stock Analysis's 205 and Renaissance Capital's 86 IPOs recorded through a comparable period; the definitional difference almost certainly traces to how blank-check vehicles are classified.
On the capital-raised side, Renaissance Capital reported $34.2 billion raised through May 31, up 163.9% from the same period a year earlier, across 113 total IPOs — itself a 10.5% year-over-year increase. The dollar figure was lifted materially by large-cap deals: Quantinuum Inc. (QNT) priced at $60 per share on June 4 in an upsized Nasdaq IPO that raised approximately $1.68 billion, illustrating where the bulk of proceeds concentrated.
Sector composition in the 2026 pipeline skewed toward late-stage technology and AI infrastructure rather than the traditional small-cap sectors — mining, biotech, community banking — that populate the microcap universe. TipRanks noted that the increase in deal count reflects, in part, fewer conventional listings rather than a dramatic surge in overall risk appetite, and that the broader story may be one of traditional IPO issuance weakness masked by SPAC volume. Artificial intelligence, cybersecurity, healthcare technology, infrastructure, and financial technology attracted the most visible investor interest, per U.S. News, with OpenAI, Anthropic, and SpaceX reported to be eyeing public offerings.
The market backdrop for the week ending July 24 added texture. Small caps have outperformed materially in 2026: the Russell 2000 is up 19.4% year-to-date against a 9.8% gain for the Nasdaq, per King5/AP. The iShares Russell 2000 ETF came off a 22% first-half gain — its best opening six months since 1991. Market leadership has broadened away from the Magnificent 7, with the Russell 1000 Value gaining 0.45% while the Russell 1000 Growth fell 3.64% in the most recent week, a spread of over four percentage points, according to Clearbrook Global's weekly commentary.
Macro crosscurrents remain real. Brent crude briefly surpassed $100 per barrel before settling at $96.78, per LPL Financial's July 24 weekly recap, as complications in reopening the Strait of Hormuz kept supply constrained. Initial jobless claims fell 22,000 in the week ending July 18 to 187,000 — the lowest level since 1969, per the Department of Labor — adding upward pressure to yields. All three major indexes finished the week lower.
The net read for microcap capital formation: deal count is running ahead of 2025, dollars raised are substantially higher, but the composition is concentrated at the large-cap and SPAC end of the market. What the Russell 2000's 19.4% year-to-date gain means for traditional small-cap IPO issuance in the second half of 2026 is a question neither Stock Analysis's count nor Renaissance Capital's capital-raised figure yet answers.